NodThera Ltd, a UK biotech company developing treatments for chronic inflammatory diseases, has appointed Greg Chow as chief financial and business officer to oversee the company’s expansion. Mr Chow is a former investment banker, and more recently CFO at Freenome Holdings which is developing tests for cancer detection. Prior to this, he asCFO at Frontier Medicines which is developing medicines in oncology and immunologoy. Mr Chow holds an MBA in finance from the Wharton School at the University of Pennsylvania and a BA in business economics from the University of California, Santa Barbara. The appointment comes two months after NodThera appointed Daniel Swisher as its new chief executive.
NodThera announced the appointment on 1 August 2024
Copyright 2024 Evernow Publishing